Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEFNCT06793371CytokineticsPhase 2Recruiting2026-09Estimated
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset SeizuresNCT06798896SUPNPhase 2Recruiting2027-08Estimated
Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia GravisNCT06799247Cartesian TherapeuticsPhase 3Active not recruiting2026-12-30Estimated
A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist UseNCT06804603Vanda PharmaceuticalsPhase 2Completed2025-10-06Actual
A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety DisorderNCT06809179VTGNPhase 2Completed2026-06-12Actual
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)NCT06809595Definium Therapeutics US, Inc.Phase 3Active not recruiting2026-08-13Actual
Long-Term Safety and Efficacy of Plozasiran in Adults With HypertriglyceridemiaNCT06822790Arrowhead PharmaceuticalsPhase 3Active not recruiting2028-07Estimated
Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular EdemaNCT06825702KPRXPhase 2Recruiting2026-11Estimated
VK2735 for Weight Management Phase 2 (Venture Oral Dosing)NCT06828055VKTXPhase 2Completed2025-06-24Actual
ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective TrialNCT06828861AARDPhase 3Terminated2026-05-07Actual
Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder CancerNCT06829823IBRXPhase 2Not yet recruiting2026-11Estimated
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive DisorderNCT06830044Vanda PharmaceuticalsPhase 3Recruiting2028-03Estimated
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney DiseaseNCT06830629Maze TherapeuticsPhase 2Recruiting2026-09Estimated
Open Label Safety Study of Tradipitant in Idiopathic and Diabetic GastroparesisNCT06836557Vanda PharmaceuticalsPhase 3Completed2026-03-30Actual
A Study of TYRA-300 in Children With Achondroplasia: BEACH301NCT06842355TYRAPhase 2Recruiting2030-01Estimated
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)NCT06842498Kyntra BioPhase 2Recruiting2028-03-31Estimated
Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)NCT06843239Zura Bio IncPhase 2Active not recruiting2027-05Estimated
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic HypersomniaNCT06843590Alkermes, Inc.Phase 2Active not recruiting2026-11Estimated
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque PsoriasisNCT06846541ALMSPhase 3Active not recruiting2028-11Estimated
NE3107 in Adults With Neurological Symptoms of Long COVIDNCT06847191BIVIPhase 2Completed2026-08-06Actual
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic PainNCT06848348DWTXPhase 2Active not recruiting2026-12Estimated
Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative ColitisNCT06850727Odyssey TherapeuticsPhase 2Recruiting2026-04Estimated
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 WeeksNCT06851559PHATPhase 2Active not recruiting2026-09-11Actual
A Study to Investigate Tonlamarsen for the Treatment of Adults With Uncontrolled Hypertension (KARDINAL)NCT06864104KARDPhase 2Completed2026-01-12Actual
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular DegenerationNCT068649884D Molecular TherapeuticsPhase 3Active not recruiting2027-06Estimated
An Open-label Long-term Follow-up Study of SAT-3247 for Participants With Duchenne Muscular Dystrophy Including Those Who Participated in SAT-3247-CL-101NCT06867107MSLEPhase 2Recruiting2027-09-30Estimated
C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCVNCT06868264AVIRPhase 3Completed2026-06-18Actual
A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)NCT06868628TLSAPhase 2Recruiting2027-04-01Estimated
A Randomised, Double-blind, Placebo-controlled Phase 2a Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONP-002 in Adults With Mild Traumatic Brain InjuryNCT06870240OGENPhase 2Not yet recruiting2026-01-01Estimated
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet SyndromeNCT06872125STOKPhase 3Active not recruiting2027-03Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.